Wolverine Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Wolverine Asset Management's NVAX Position: Q3 2026 in Review
Wolverine Asset Management reduced its Novavax (NVAX) stake by 19% in Q3 2026, selling an estimated $62.7K and leaving 30,037 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.
Wolverine Asset Management first reported a position in NVAX in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.43M in Q1 2023. 220 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- Wolverine Asset Management held 30,037 shares of Novavax worth $325K as of Q3 2026.
- Wolverine Asset Management sold 7,000 Novavax shares in Q3 2026, an estimated $62.7K.
- Novavax made up ﹤0.01% of Wolverine Asset Management's portfolio in Q3 2026, its #1092 holding.
- Wolverine Asset Management first reported a position in Novavax in Q4 2018 and has held it in 13 quarters since.
- Wolverine Asset Management's Novavax position peaked at $2.43M in Q1 2023.
- 220 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.